Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA’s Final CGT Guidance Brings Clarity
CGT Designation Does Not Mean Shorter Review Time
Mar 18 2020
•
By
Akriti Seth
FDA issues clarifications in the final CGT guidance • Source: Shutterstock
More from Regulation
More from Policy & Regulation